ANGLE plc (ANPCF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.67 Million GBP | -18.46% |
| 2022 | 2.05 Million GBP | 17.79% |
| 2021 | 1.74 Million GBP | 135.58% |
| 2020 | 742 Thousand GBP | -5.84% |
| 2019 | 788 Thousand GBP | -20.24% |
| 2018 | 988 Thousand GBP | 64.94% |
| 2017 | 599 Thousand GBP | -9.92% |
| 2016 | 665 Thousand GBP | 76.86% |
| 2015 | 376 Thousand GBP | 90.86% |
| 2014 | 197 Thousand GBP | 278.85% |
| 2013 | 52 Thousand GBP | -16.48% |
| 2012 | 62.26 Thousand GBP | 0.0% |
| 2011 | - GBP | 0.0% |
| 2010 | - GBP | 0.0% |
| 2009 | - GBP | 0.0% |
| 2008 | - GBP | 0.0% |
| 2007 | - GBP | 0.0% |
| 2006 | - GBP | 0.0% |
| 2005 | - GBP | 0.0% |
| 2004 | - GBP | 0.0% |
| 2003 | - GBP | 0.0% |
| 2002 | - GBP | 0.0% |
| 2001 | - GBP | 0.0% |
| 2000 | - GBP | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.76 Million GBP | 0.0% |
| 2024 Q1 | 1.76 Million GBP | 4.88% |
| 2023 Q1 | 2.25 Million GBP | 9.57% |
| 2023 FY | 1.67 Million GBP | -18.46% |
| 2023 Q3 | 1.67 Million GBP | -25.58% |
| 2023 Q4 | 1.67 Million GBP | 0.0% |
| 2023 Q2 | 2.25 Million GBP | 0.0% |
| 2022 Q3 | 2.05 Million GBP | 18.74% |
| 2022 Q2 | 1.73 Million GBP | 0.0% |
| 2022 Q1 | 1.73 Million GBP | -0.8% |
| 2022 FY | 2.05 Million GBP | 17.79% |
| 2022 Q4 | 2.05 Million GBP | 0.0% |
| 2021 Q2 | 1.07 Million GBP | 0.0% |
| 2021 Q4 | 1.74 Million GBP | 0.0% |
| 2021 FY | 1.74 Million GBP | 135.58% |
| 2021 Q1 | 1.07 Million GBP | 45.01% |
| 2021 Q3 | 1.74 Million GBP | 62.45% |
| 2020 Q2 | 905 Thousand GBP | 0.0% |
| 2020 Q4 | 742 Thousand GBP | 0.0% |
| 2020 Q3 | 742 Thousand GBP | -18.01% |
| 2020 FY | 742 Thousand GBP | -5.84% |
| 2020 Q1 | 905 Thousand GBP | 0.0% |
| 2019 Q3 | 847 Thousand GBP | -3.75% |
| 2019 Q1 | 988 Thousand GBP | 0.0% |
| 2019 FY | 788 Thousand GBP | -20.24% |
| 2019 Q2 | 880 Thousand GBP | -10.93% |
| 2018 Q1 | 599 Thousand GBP | 0.0% |
| 2018 Q3 | 880 Thousand GBP | 0.0% |
| 2018 FY | 988 Thousand GBP | 64.94% |
| 2018 Q4 | 988 Thousand GBP | 12.27% |
| 2017 Q4 | 599 Thousand GBP | -29.86% |
| 2017 Q3 | 854 Thousand GBP | 0.0% |
| 2017 Q2 | 854 Thousand GBP | 28.42% |
| 2017 Q1 | 665 Thousand GBP | 0.0% |
| 2017 FY | 599 Thousand GBP | -9.92% |
| 2016 Q2 | 631 Thousand GBP | 67.82% |
| 2016 Q1 | 376 Thousand GBP | 0.0% |
| 2016 Q3 | 631 Thousand GBP | 0.0% |
| 2016 Q4 | 665 Thousand GBP | 5.39% |
| 2016 FY | 665 Thousand GBP | 76.86% |
| 2015 FY | 376 Thousand GBP | 90.86% |
| 2015 Q2 | 271 Thousand GBP | 37.56% |
| 2015 Q3 | 271 Thousand GBP | 0.0% |
| 2015 Q4 | 376 Thousand GBP | 38.75% |
| 2015 Q1 | 197 Thousand GBP | 0.0% |
| 2014 Q3 | 106 Thousand GBP | 0.0% |
| 2014 Q4 | 197 Thousand GBP | 85.85% |
| 2014 FY | 197 Thousand GBP | 278.85% |
| 2014 Q2 | 106 Thousand GBP | 103.85% |
| 2014 Q1 | 52 Thousand GBP | 0.0% |
| 2013 FY | 52 Thousand GBP | -16.48% |
| 2013 Q2 | 15 Thousand GBP | -75.91% |
| 2013 Q3 | 15 Thousand GBP | 0.0% |
| 2013 Q4 | 52 Thousand GBP | 246.67% |
| 2013 Q1 | 62.26 Thousand GBP | 0.42% |
| 2012 FY | 62.26 Thousand GBP | 0.0% |
| 2012 Q4 | 62 Thousand GBP | 1491.78% |
| 2012 Q3 | 3895.00 GBP | 0.0% |
| 2012 Q2 | 3895.00 GBP | 0.0% |
| 2012 Q1 | - GBP | 0.0% |
| 2011 FY | - GBP | 0.0% |
| 2011 Q3 | - GBP | 0.0% |
| 2011 Q1 | - GBP | 0.0% |
| 2010 Q3 | - GBP | 0.0% |
| 2010 FY | - GBP | 0.0% |
| 2010 Q1 | - GBP | 0.0% |
| 2009 Q3 | - GBP | 0.0% |
| 2009 Q1 | - GBP | 0.0% |
| 2009 FY | - GBP | 0.0% |
| 2008 FY | - GBP | 0.0% |
| 2008 Q3 | - GBP | 0.0% |
| 2008 Q1 | - GBP | 0.0% |
| 2007 FY | - GBP | 0.0% |
| 2007 Q3 | - GBP | 0.0% |
| 2007 Q1 | - GBP | 0.0% |
| 2006 Q1 | - GBP | 0.0% |
| 2006 FY | - GBP | 0.0% |
| 2006 Q3 | - GBP | 0.0% |
| 2005 Q1 | - GBP | 0.0% |
| 2005 FY | - GBP | 0.0% |
| 2005 Q3 | - GBP | 0.0% |
| 2004 Q3 | - GBP | 0.0% |
| 2004 Q1 | - GBP | 0.0% |
| 2004 FY | - GBP | 0.0% |
| 2003 FY | - GBP | 0.0% |
| 2003 Q3 | - GBP | 0.0% |
| 2002 FY | - GBP | 0.0% |
| 2001 FY | - GBP | 0.0% |
| 2000 FY | - GBP | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | -343.008% |
| Arrayit Corporation | 464.19 Thousand USD | -261.704% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | -121.797% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 70498.323% |
| DermTech, Inc. | 1 Million USD | -67.231% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 49.108% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | -84.642% |
| iMD Companies, Inc. | 38.31 Thousand USD | -4281.981% |
| IDenta Corp. | 442.28 Thousand USD | -279.623% |
| Interpace Biosciences, Inc. | 1.22 Million USD | -36.838% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -929.209% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | -114.158% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 447833.333% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | -258.168% |
| PharmChem, Inc. | 391.93 Thousand USD | -328.385% |
| Proteome Sciences plc | 1.06 Million USD | -57.578% |
| Response Genetics, Inc | 133 Thousand USD | -1162.406% |
| Rennova Health, Inc. | 242.64 Thousand USD | -591.957% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -2172.081% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -1655.89% |
| Todos Medical Ltd. | 1.02 Million USD | -64.447% |